← Leaderboards
John A Heit
Mayo Clinic Coll Of Medicine, Rochester
$17,456,146
Attributed
$18,600,408
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$17,525,408 · 9
CDC$1,075,000 · 1
By mechanism
R01$12,997,352 · 4
K12$2,877,114 · 1
U01$2,208,250 · 2
U54$494,283 · 1
M01$23,409 · 2
Top collaborators
- Kent R Bailey4 shared
- Virginia M Miller4 shared
- Whyte G Owen4 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Virginia M Miller$9,622,525
- Kent R Bailey$4,588,162
Others in their field
Top investigators on “Thromboembolism”
- Jeffrey Lee Carson · Univ Of Med/Dent Nj-R W Johnson Med Sch$24,743,468
- Thomas L Ortel · Duke University$24,036,836
- Howard N Hodis · University Of Southern California$22,559,370
- Danny Bluestein · State University New York Stony Brook$12,609,013
- Guy L Reed · Harvard University (Sch Of Public Hlth)$11,832,375
- Alan S Go · University Of California San Francisco$11,195,905
Research focus
ThromboembolismBaseVenousIncidenceThrombosisCountyRisk FactorsProgramsGenderVenous ThrombosisClinical ResearchPhysiciansPreventMedicalPreventionMedicineProphylactic TreatmentResearch PersonnelMalignant NeoplasmsResourcesOperative Surgical ProceduresCohortAcuteFunding
Grant awards (44)
Risk Factors for Venous Thromboembolism in the Community$669,010
R01 · FY2014 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$644,723
R01 · FY2013 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$681,242
R01 · FY2012 · HL · contact PI
Mayo Clinic Vascular Medicine Clinical Research Training Program$1
K12 · FY2012 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$690,877
R01 · FY2011 · HL · contact PI
Estrogen, Platelets, and Artherosclerosis$376,457
R01 · FY2011 · HL
Mayo Clinic Thrombosis and Hemostasis Research Center$175,000
U01 · FY2011 · DD · contact PI
Risk Factors for Venous Thromboembolism in the Community$697,856
R01 · FY2010 · HL · contact PI
Estrogen, Platelets, and Artherosclerosis$387,948
R01 · FY2010 · HL
Mayo Clinic Thrombosis and Hemostasis Research Center$200,000
U01 · FY2010 · DD · contact PI
Mayo Clinic Vascular Medicine Clinical Research Training Program$849,517
K12 · FY2009 · HL · contact PI
Individual Propensity to Venous Thrombosis$789,941
R01 · FY2009 · HL · contact PI
GWAS of Venous Thrombosis$566,625
U01 · FY2009 · HG · contact PI
Estrogen, Platelets, and Artherosclerosis$378,300
R01 · FY2009 · HL
Mayo Clinic Thrombosis and Hemostasis Research Center$280,000
U01 · FY2009 · DD · contact PI
Mayo Clinic Vascular Medicine Clinical Research Training Program$995,263
K12 · FY2008 · HL · contact PI
Individual Propensity to Venous Thrombosis$754,005
R01 · FY2008 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$594,841
R01 · FY2008 · HL · contact PI
GWAS of Venous Thrombosis$566,625
U01 · FY2008 · HG · contact PI
Estrogen, Platelets, and Artherosclerosis$382,978
R01 · FY2008 · HL
Mayo Clinic Thrombosis and Hemostasis Research Center$220,000
U01 · FY2008 · DD · contact PI
Natural History of Patients with Elevated Antibody Levels to Heparin$55,461
U54 · FY2008 · HL · contact PI
Individual Propensity to Venous Thrombosis$758,665
R01 · FY2007 · HL · contact PI
Mayo Clinic Vascular Medicine Clinical Research Training Program$666,882
K12 · FY2007 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$587,653
R01 · FY2007 · HL · contact PI
Mayo Clinic Thrombosis and Hemostasis Research Center$200,000
U01 · FY2007 · DD · contact PI
Natural History of Patients with Elevated Antibody Levels to Heparin$58,317
U54 · FY2007 · HL · contact PI
Individual Propensity to Venous Thrombosis$737,127
R01 · FY2006 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Comminity$589,694
R01 · FY2006 · HL · contact PI
Mayo Clinic Vascular Medicine Clinical Research Training Program$365,451
K12 · FY2006 · HL · contact PI
Natural history ofelevated antibody levels to heparin$126,835
U54 · FY2006 · HL · contact PI
Risk Factors for Venous Thromboembolism in the Community$567,073
R01 · FY2005 · HL
Natural history ofelevated antibody levels to heparin$126,835
U54 · FY2005 · HL
RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN THE COMMUNITY$19,192
M01 · FY2005 · RR
MANAGEMENT OF MENORRHAGIA IN WOMEN WITH BLEEDING DISORDERS$2,132
M01 · FY2005 · RR
RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN THE COMMUNITY$461,942
R01 · FY2004 · HL
Natural history ofelevated antibody levels to heparin$126,835
U54 · FY2004 · HL
Management of Menorrhagia in Women with Bleeding Disorders$1,390
M01 · FY2004 · RR
Risk Factors for Venous Thromboembolism in the Community$695
M01 · FY2004 · RR
RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN THE COMMUNITY$488,185
R01 · FY2003 · HL
RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN THE COMMUNITY$486,442
R01 · FY2002 · HL
RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN THE COMMUNITY$475,864
R01 · FY2001 · HL
GENETIC EPIDEMIOLOGY OF VENOUS THROMBOEMBOLISM$402,804
R01 · FY2001 · HL
GENETIC EPIDEMIOLOGY OF VENOUS THROMBOEMBOLISM$393,725
R01 · FY2000 · HL